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An inherent difficulty in using DNA microarray technology on the early mouse embryo is its relatively small size. In this study, we investigated
whether use of ES cell differentiation culture, which has no theoretical limit in the number of cells that can be generated, can improve this
situation. Seven distinct ES-cell-derived populations were analyzed by DNA microarray and examined for genes whose distribution patterns are
similar to those of PDGFRα, a gene implicated in differentiation of mesoderm/mesenchymal lineages. Using software developed in our laboratory,
we formed a group of 30 genes which showed the highest similarity to PDGFRα, 18 of these genes were shown to be involved in development of
either mesodermal, mesenchymal or neural crest cells. This list also contains several genes whose role in embryogenesis has not yet been fully
identified. One such molecule is mARID3b. The mARID3b expression is found in the paraxial mesoderm and cranial mesenchyme. mARID3b-
null mouse showed early embryonic lethality, and most phenotypes of this mutant appear to develop from a failure to generate a sufficient number
of cranial mesenchymal cells. These results demonstrate the potential use of ES cell differentiation culture in identifying novel genes playing an
indispensable role in embryogenesis.
© 2005 Elsevier Inc. All rights reserved.Keywords: ES cell; In vitro differentiation; DNA microarray; PDGFRα; ARID3bIntroduction
While current mouse molecular genetics has progressed to a
level in which the function of a particular gene expressed in the
early embryo can be characterized to a large extent, the mouse
embryo, due to its small size, remains a difficult subject in
which to identify novel genes. In most cases, this has meant
performing gene cloning on sources other than the actual
embryo or isolating mouse homologues of genes known to play
a role in the development of other species in which gene cloning
is easier than in mouse embryo (Anderson and Ingham, 2003;⁎ Corresponding author.
E-mail address: tera@cdb.riken.jp (T. Era).
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doi:10.1016/j.ydbio.2005.12.016Chen and Ekker, 2004; Gehring, 1993). Although both these
alternative methods are effective in revealing the molecules
underlying early mouse embryogenesis, isolating novel genes
directly from mouse embryos would be of considerable use to
researchers in this field.
One alternative strategy for obtaining cells corresponding to
those in the mouse embryo is to use mouse embryonic stem
(mES) cells (Loebel et al., 2003). As an in vitro mES cell culture
can undergo unlimited growth while maintaining pluripotency,
it is potentially an ideal source of a sufficient number of
embryonic cells required for studies such as DNA microarray
analysis. However, mES cell differentiation culture has not yet
become a popular method for cloning genes involved in early
embryogenesis as it still remains difficult to obtain pure
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diversification (Aubert et al., 2002; Jackson et al., 2002).
We have developed a set of surface markers that recognize
various intermediate stages during differentiation of mesoder-
mal/mesenchymal cells (Nishikawa et al., 1998). Vascular
endothelial growth factor receptor 2 (VEGFR2), a receptor type
tyrosine kinase, is expressed in lateral and extra-embryonic
mesodermal cells at the gastrula stage (Yamaguchi et al., 1993).
Our group and others have demonstrated that ES-cell-derived
VEGFR2+ cells can give rise to both endothelial cells (ECs) and
hematopoietic cells (HPCs) that are progenies of lateral and
extra-embryonic mesoderms (Kabrun et al., 1997; Wang et al.,
2004; Yamashita et al., 2000). This suggests that ES-cell-
derived VEGFR2+ cells correlate significantly with VEGFR2+
cells in actual embryos.
In addition to VEGFR2+ cells, another receptor type of
tyrosine kinase, platelet derived growth factor receptor α
(PDGFRα), has been used to monitor the differentiation
pathways in ES cell development (Kataoka et al., 1997;
Nishikawa et al., 1998). Though PDGFRα is involved in the
development of multiple cell lineages and begins to regularly
appear from an early stage of embryogenesis (Soriano, 1997),
its expression at 7.5 dpc and 8.5 dpc is mainly observed in two
lineages; one is in mesodermal cells including paraxial
mesoderm and somites, the other is in neural crest cells
(NCC) and cranial mesenchymal cells (Takakura et al., 1997).
Nascent mesodermal cells, mesenchymal cells and NCC begin
to express PDGFRα upon transition from epithelial structures
such as epiblasts and neuroepithelial cells (Schatteman et al.,
1992). The phenotype of the PDGFRα-null mutant also
suggested a common role for this receptor in development of
mesodermal, mesenchymal and NCC lineages (Soriano, 1997;
Tallquist and Soriano, 2003), implying that a common
molecular mechanism underlies the generation of these lineages
and that a part of this mechanism is also involved in expression
of PDGFRα.
In our previous study, we analyzed the expression of
PDGFRα and VEGFR2 in ES cell differentiation culture and
defined four subpopulations, PDGFRα+VEGFR2+, PDGFRα−
VEGFR2+, PDGFRα+VEGFR2− and PDGFRα−VEGFR2−
(Nishikawa et al., 1998). While VEGFR2+ cells in this culture
correspond to lateral mesodermal cells in the actual embryo, we
and others showed PDGFRα+VEGFR2− population includes
paraxial mesoderm that can give rise to bone, cartilage and
muscle cells (Nakayama et al., 2003; Sakurai et al., in press).
The process by which ES cells differentiate to PDGFRα+ cells
may represent, at least to some extent, a common process
required for generation of PDGFRα+ cells from epithelial
structures. One advantage of this experimental system is that
PDGFRα can be used as a marker both for searching genes
associated with this process and for purifying a sufficient
number of PDGFRα+ cells for analyses.
We have been developing and establishing methods for
selectively inducing ES cells to specific cell lineages
corresponding to the three germ layers in actual embryos. To
facilitate this process, gene expression profiles from ES-cell-
derived cell populations were routinely created using Affyme-trix oligonucleotide arrays. The expression profiles of the DNA
microarray were stored and accumulated for use as a database,
allowing the entire data set to be easily queried. By searching
for genes showing a similar expression pattern to PDGFRα, the
database was used to find genes regulating paraxial mesoderm
and/or mesenchymal differentiation. Our analyses identified
and listed a group of genes known to be important in
differentiation of paraxial mesoderm, NCC and/or cranial
mesenchymal cells. In addition to these extensively studied
molecules, we also identified several molecules whose role in
embryogenesis remains unknown.
In order to confirm the validity of our approach to discover
novel genes, we chose the murine AT-rich interacting domain
protein 3b (mARID3b) gene from this list of genes and
characterized it in detail during in vivo embryogenesis. At 9.5
dpc, this molecule was expressed in both cranial mesenchyme
and caudal mesoderm where PDGFRα expression overlaps
(Takakura et al., 1997; Weston et al., 2004). Cardiovascular
defects in mARID3b-null mice ensure embryonic lethality
before 11.5 dpc, and the generation of cranial–mesenchymal
cells in the first and second branchial arches (BA1 and BA2)
was also found to be severely impaired. In mutant mice,
mARID3b-expressing mesenchymal cells differentiated and
migrated normally but failed to be maintained in BA1 and BA2.
This study demonstrates that DNA microarray analysis of cells
in ES cell differentiation culture is useful for identifying genes
such as mARID3b, whose role in mouse embryogenesis has not
yet been well characterized.
Materials and methods
ES cell culture and in vitro ES cell differentiation
CCE ES cells were maintained as described previously (Era and Witte,
2000). For gene targeting, TT2 ES cell lines were maintained as described
previously (Yagi et al., 1993).
Induction of ES cell differentiation was performed as described previously
(Nishikawa et al., 1998). CCE ES cells were seeded into 10-cm dishes coated
with type IV collagen (BioCoat; Becton Dickinson Labware) at a density of 105
cells per dish in conditions of αMEM supplemented with 10% FCS and 50 μM
2-mercaptoethanol.
Antibodies and cell staining for FACS analysis and sorting
Rat MoAbs, APA5 (anti-PDGFRα) and AVAS12 (anti-VEGFR2) were
prepared as described previously (Kataoka et al., 1997; Takakura et al., 1996).
APA5 and AVAS12 were conjugated with biotin and allophycocyanin,
respectively. Phycoerythrin-conjugated streptavidin (Pharmingen) was used to
detect biotinylated-APA5 antibodies. For FACS analysis and sorting, day-4-
differentiated ES cells were harvested and stained with these antibodies as
described previously (Nishikawa et al., 1998).
Hybridization of cRNA to the oligonucleotide arrays
See Supplementary Fig. 6 information.
Bioinformatics analyses
Expression data from a number of samples were stored and analyzed using
the eXintegrator system (http://www.cdb.riken.jp/scb/documentation/index.
html).
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software (Affymetrix). The raw data in the Excel files were further analyzed
using bioinformatics tools, NetAffix (Affymetrix) or an original Data analysis
software, (Patent No. 2003-2945531). Genes were represented on Affymetrix
arrays by sets of probes (known as probe sets) containing a number of paired
probes, with each probe containing a background control. Comparisons in this
analysis were carried out using individual probe pair profiles (foreground–
background) rather than profiles of aggregate values for individual probe sets.
Data from individual arrays were normalized by the median of the probe
intensities on those chips before further analysis. Individual probe pair profiles
were then normalized across the set of samples in the database by subtracting the
mean and dividing by the standard deviation. Expression similarity values for
pairs of probe sets were taken as the mean value of a set of all-against-all probe
pair profile Euclidean distances (i.e. for two probe sets with 16 probes each, a
total of 256 Euclidean distances were calculated and the mean of those distances
taken). This calculation provides not only a measure of the similarity of the
aggregate expression profile but also of the quality of the underlying data (as
evidenced by co-variation of individual probe pair profiles).
Gene targeting
The 5′ and 3′ arms of the targeting construct were amplified from phage
clones carrying mARID3b genomic genes by PCR method. Primers were:
GCATCTTTAGCCTGCTCTGTTCTGC (forward) and GCTGCAGAGGCTC-
CATTACTGTCT (reverse) for the 5′ genomic arm, and TAAGCAGGT-
CAGTCTTTCTGCTG (forward) and AAGCCATGTTTAAGGGCTGG
(reverse) for the 3′ genomic arm. The exon containing the ATG start codon
was completely replaced by an internal ribosomal entry site (IRES)-β-
galactosidase (LacZ) and PGK-Neo cDNAs flanked by loxP sites followed.
After transfection, G418-resistant 150 colonies were selected and 8 correctly
targeted clones obtained by Southern blot analysis. The probe was also
amplified by PCR (forward—TTAAGCAGGTCAGTCTTTCT reverse—
TCTAGAAACTAATTAGAACC). After transient expression of a Cre recombi-
nase vector (Araki et al., 1997), the removal of the PGK-Neo cassette was
confirmed by both sensitivity to G418 and Southern blot analysis. Two lines of
chimeric mice were generated from two independent mARID3b+/− ES cell
lines.
Breeding and genotyping of mice and embryos
Backcross mating to the C57BL/6 strain was performed more than five
times. Tail tips or yolk sacs were used for genotyping by Southern blot analysis.
Northern blot analysis
mARID3b probe was amplified by PCR (primers: forward—ACAA-
GACTCCCTTCTGATCCTCA and reverse—ATGGAGCCCTGGA-
TAAGGTCTA) using cDNA of day-4-differentiated ES cells and labeled with
αP32-dCTP by Megaprime DNA labeling System (Amersham). Commercially
available membranes–MTN™ (Multi Tissue Northern blot) 1, 2 (BD)–were used,
and hybridization was performed according to the manufacturer's instructions.
Membranes were re-hybridized with the probe for β-actin.
Whole-mount and section samples in situ hybridization
In situ hybridization was performed as described in the Anderson laboratory
protocols (http://www.rodentia.com/wmc/docs/Big_In_Situ.html). Embryos
were fixed in 4% paraformaldehyde overnight, and cryosections were used for
section ISH. Anti-sense RNA probes were prepared from the probe construct in
Northern blot analysis and labeled by DIG Labeling Kit (Roche) in accordance
with the manufacturer's instructions. We used sense RNA probes as negative
controls.1 An Open source client-server system for the analysis of Affymetrix
microarray data. L.M. Jakt, M. Okada, S. Nishikawa (Genome Informatics
Series (ISSN 0919-9454) No. 14, pp. 276–277, GIW 2003).Histological analysis
For histological analysis, embryos were fixed in 4% paraformaldehyde
overnight and embedded in paraffin wax for sectioning. Generally, 4-μm
sections were cut and stained with Hematoxylin–Eosin or DAPI.
Terminal transferase-mediated dUTP-biotin nick end-labeling (TUNEL)
assay was performed by ApoAlert DNA Fragmentation Assay Kit (BD).
Apoptotic nuclei were visualized by green fluorescence and detected by
confocal microscopy according to the instruction manual.
For LacZ staining, Embryos were fixed by 2% formaldehyde; 0.2%
glutaraldehyde; 0.02% Nonidet P-40; 0.2 mMMgCl2/phosphate-buffered saline
(PBS) for 20 h and washed with 0.2 mMMgCl2; 0.02% Nonident P-40/PBS and
stained overnight with X-gal stain. Endothelial cell staining of whole-mount
embryos and yolk sacs were performed using CD31 (PECAM1) antibody
(Pharmingen) as described previously (Yamashita et al., 2000). Whole-mount
immunohistostaining of PDGFRα antibody (antibody name: APA5) was
performed according to the protocol described in previous report (Takakura et
al., 1997).Results
Identification of genes whose expression pattern is similar to
that of PDGFRα
The expression of PDGFRα is mainly observed in cranial
mesenchyme, paraxial mesoderm and somites during early
mouse embryogenesis (Supplementary Fig. 1) (Takakura et al.,
1997; Zhang et al., 1998). Our previous studies showed that this
particular gene could be used to monitor the differentiation of
paraxial mesoderm and mesenchymal cells during in vitro ES
cell differentiation (Fig. 1A) (Kataoka et al., 1997; Nishikawa et
al., 1998). Our recent experiments demonstrated that
PDGFRα+VEGFR2+ progenitors could give rise to both
PDGFRα+VEGFR2− and PDGFRα−VEGFR2+ populations,
the former has a potential to give rise to the mesenchymal cell
lineage while the latter corresponds to lateral mesoderm (Figs.
1A and B) (Sakurai et al., in press). This putative model for ES
cell differentiation to PDGFRα+ cells implies that this process
could be used as a model for the transition of epithelial cells to
PDGFRα+ mesenchymal cells.
We have accumulated data of DNA microarray analysis
of various intermediates in ES cell differentiation culture
and defined them in terms of differentiation markers that
are utilized for cell sorting by FACS. In addition to the
three populations described above, this database contained
VE-cadherin+ cells, undifferentiated ES cells, aortic endo-
thelial cells and VEGFR2+ cells that were not fractionated
further, thus including both PDGFRα+ and PDGFRα−
populations.
To isolate the candidate genes, gene expression patterns
were simply compared with those of PDGFRα. Affymetrix
probe sets were sorted by similarity of expression to a probe
set representing PDGFRα using a modified Euclidean
distance measurement (Fig. 1C, and see Materials and
methods). This method of data mining was expected to
identify genes that exhibit similar expression patterns to
PDGFRα in vivo. Table 1 and Supplementary Fig. 2 list the
30 genes with expression patterns of highest similarity to
PDGFRα. To date, 24 out of the 30 genes in the list have
Fig. 1. DNAmicroarray analyses of ES-cell-derived PDGFRα+ populations. (A) Expression patterns of PDGFRα and VEGFR2 during in vitro ES cell differentiation.
Undifferentiated ES cells do not express either receptor (left panel), whereas day-4-differentiated ES cells do (right panel). On day 4, differentiated ES cells expressing
both markers are classified into three populations, PDGFRα+VEGFR2+, PDGFRα+VEGFR2− and PDGFRα−VEGFR2+. (B) A model for differentiation from ES cells
to PDGFRα+ and VEGFR2+ cell lineages. Our previous analysis revealed three types of cell population in day-4-differentiated ES cells. The PDGFRα+VEGFR2+
population can give rise to both PDGFRα−VEGFR2+ and PDGFRα+VEGFR2− populations. PDGFRα−VEGFR2+ cells eventually differentiate into endothelial and
hematopoietic cells. However, our data indicated that PDGFRα+VEGFR2− cells display very similar differentiation potential to paraxial mesoderm and mesenchymal
cells in actual mouse embryos (Sakurai et al., in press). (C) Procedure to select genes showing similar expression patterns to that of PDGFRα. Microarray data of seven
distinct populations, undifferentiated ES cells (ES), PDGFRα+VEGFR2+ cells (P+V+), PDGFRα+VEGFR2− cells (P+V−), PDGFRα+VEGFR2+ cells (P−V+),
VEGFR2+ cells (V+) that contain both PDGFRα+ and PDGFRα− cells, VE-cadherin + cells (VE+) and aortic endothelial cells (Ao) were selected from our database.
The upper panel shows relative expression level of PDGFRα in each population. Each value connected by the lines represents data of different oligo-probes for
PDGFRα gene, which are normalized so as to reduce the variation among probes (see Materials and methods). To simplify analyses, mean values of expression
intensities are also measured and blotted (lower panel and Supplementary Fig. 2). Genes that showed a similar expression pattern to PDGFRα (yellow line) were
selected by our software as described in Materials and methods. Lhx1 (red line) is the gene ranked as the closest match. The patterns of the top 30 genes are presented in
Supplementary Fig. 2.
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and phenotype analyses of gene knock out mice have been
reported for 22 of them (references in Supplementary Fig.
3). Eighteen genes are expressed in mesodermal and
mesenchymal cells, and, more specifically, thirteen of them
show more restricted expression patterns in either paraxial
mesoderm or cranial mesenchyme (indicated by a star in
Table 1). Seven of the genes, #7 (Mesp1), #9 (Lfng), #20
(Gsc), #22 (Cyp26), #23 (Msx2), #28 (Msx1) and #30
(Pitx2), were shown to be embryonic lethal by null mutation
due to obvious defects in the differentiation of paraxial
mesoderm or cranial mesenchymal cells (Supplementary Fig.3). Among transcriptional factors in the list, null mutant
mice of gene encoding #1 (Lhx1), #4 (Eomes), #10 (Sna),
#18 (Six2), #24 (Sox4) and #29 (Lef1) have been reported
to display defects in development of either mesodermal,
mesenchymal or both. This list contains also cadherins, such
as #15 (Cdh11) and #26 (Cdh2), whose roles were
implicated in the migration of NCC during the epithelial–
mesenchymal transition. #3 (Sfp3), #14 (Smad1) and #16
(Rbp1) are signaling molecules that are known to be
involved in Wnt, BMP and retinoic acid, respectively,
which are crucial in the development of many cell lineage
including mesoderm and mesenchyme.
Table 1
List of the top 30 genes showing highest similarity of expression patterns to PDGFRα expression
Expression sites of each listed gene in 7.5–9.5 dpc embryos are described and represented by color marks as indicated in the table. Eighteen out of 30 genes in this list
are expressed either in mesodermal or mesenchymal cells. Five of them, #1, #3, #9, #15 and #26, are expressed in both. While most of them have been characterized to
some extent, data concerning the functions of #8, #11, #21 and #25 in embryogenesis are not available to date. Asterisk marks 13 of 30 genes which exhibit the restricted
expression in either paraxial mesoderm or cranial mesenchyme.
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those genes are listed by a simple coincidence, we believe that
many of genes in this list are indeed known to be involved in
development of mesodermal/mesenchymal cells as we have
expected. Hence, our approach using DNA microarray analysis
in ES cell differentiation culture is useful for mining genes that
play an indispensable role in a particular process of mouse
embryogenesis.
ARID3b gene
As the functions and expression patterns of the four
molecules in this list, #8 (unknown), #11 (mARID3b), #21
(unknown) and #25 (Rab34) remain uncharacterized, their
expression patterns in early mouse embryo were initiallyassessed by whole-mount in situ hybridization (ISH). While
we succeeded to obtain specific staining by using probe of
#11 (mARID3b), further experiments are still needed for
determine expression pattern of other three genes. In addition,
the complete cDNA sequences of mARID3b were available in
the NCBI database, though its role in embryogenesis remains
uncharacterized. Hence, we decided to focus on mARID3b in
this study.
ARID3 is divided into two molecules, 3a and 3b, which
are encoded by distinct genes (Kortschak et al., 2000). The
deduced amino acid sequence of mARID3b (568a.a) is very
similar to human ARID3B (hARID3B) (560a.a.) (85%
homology of amino acids). Though the overall similarity
between mARID3b and hARID3a is not so high (39.6%), a
high degree of similarity among DNA binding domains is
30 A. Takebe et al. / Developmental Biology 293 (2006) 25–37conserved among ARID3 molecules (84%) (Supplementary
Fig. 4).
ARID3B was originally discovered as a protein binding to
Rb1 (Numata et al., 1999), one of the major cell cycle
regulators (Weinberg, 1991), and itself a member of the
ARID family with an ARID motif that can bind to an AT-
rich DNA sequence (Iwahara et al., 2002). The ARID family
members are conserved from yeast to human and have been
shown to be involved in a number of processes including
cell cycle regulation, senescence bypass, transcriptional
regulation and chromatin regulation (Kortschak et al.,
2000; Wilsker et al., 2002). In particular, Dri, the homologue
of ARID3 in Drosophila, plays an essential role in early
embryogenesis (Shandala et al., 1999). The similarity of
expression patterns between PDGFRα and mARID3b, as
well as the function of the ARID family molecules during
embryogenesis, led us to characterize mARID3b in detail toFig. 2. Expression of mARID3b in mouse adult tissues and embryo. (A) Northern blot
is detected in testes. A weak signal is observed in prostate, thyroid and thymus (up
mARID3b expression in mouse embryo. Whole-mount in site hybridization (ISH) (B
streak, paraxial mesoderm and in the junction between neural and surface ectoderm (B
in the neural plate, prorhombomere, tail bud and precaudal somites (C, upper: ante
observed in the distal region of BA1 (D), from the proximal to the distal region of th
somitic mesoderm (lower panel in E) and the distal end of the neural tube (lower pane
by arrowhead). ISH of sections. (G–N) Sectioned levels are indicated in panels C and
prorhombomere (G), dorsal part of the first branchial groove that contains the prospe
also observed in caudal neuroepithelium (I). In 9.5 dpc embryo (J–N), mARID3b is
the lateral portion of OV (K), BA2 and the surface of BA1 (K), a pharyngeal ec
mesenchyme at the caudal region (M) and the neural tube at the caudal end (N). Abbre
(NT) neural tube; (OV) optic vesicle; (BP) branchial pouch; (OFT) outflow tract. Scdetermine its role in the differentiation of paraxial mesoderm
and mesenchymal cells.
ARID3b expression
In addition to the similarity of the predicted protein
sequences, the expression pattern of mARID3b in adult tissues
is very similar to that of hARID3b (Numata et al., 1999). A
single 4.2 kbp mRNA with the highest signal was detected in
testes by Northern blot analysis, while weaker expression was
also detected in prostate, thyroid and thymus. No signal was
detected in other organs, including liver, spleen, heart, brain,
lung, muscle and kidney (Fig. 2A).
mARID3b expression during early embryogenesis was
then analyzed using a whole-mount ISH technique. It is first
detected in 7.0–7.5 dpc embryos at the boundary of the
primitive streak and paraxial mesoderm and also at theanalysis of mARID3b gene in mouse adult tissues. The strongest signal (4.2 kbp)
per panel). β-actin probe was used as a positive control (lower panel). (B–N)
–F). In 7.5 dpc embryo, mARID3b is expressed at the boundary of the primitive
, upper: anterior view and lower: lateral view). In 8.5 dpc embryo, it is expressed
rior view and lower: lateral view). In 9.5 dpc embryo (D and E), expression is
e BA2 (D), precaudal somites (upper panel in E, indicated by arrowheads), pre-
l in E). In 10.5 dpc, this expression disappears except for the tail tip (F, indicated
D. In 8.5 dpc embryo (G–I), mARID3b is expressed in the neuroepithelium of the
ctive BA2 (H, arrowhead) and the ectoderm in BA1 (H, arrow). Its expression is
expressed in the facio-acoustic neural crest complex (J), mesenchymal tissues in
toderm of 2nd BP (L), a wall of outflow tract (L), pre-somitic mesoderm and
viations: (A) anterior; (P) posterior; (NE) neuroepithelium; (BA) branchial arch;
ale bars: 200 μm (B–F, J–M); 100 μm (G, H, N).
Fig. 3. Generation of mARID3b-null mouse. (A) Strategy for producing
mARID3b-null mouse. The exon, including the starting codon, is replaced by an
internal ribosomal entry site (IRES) and a LacZ cassette. Endogenous mARID3b
expression can be tracked by the expression of LacZ. The PGK-neo cassette
(Neo) is flanked by loxP sites (triangles) for subsequent removal by cre-
recombinase. The flanking genomic probes used for Southern blot hybridization
are highlighted by thick lines. RI: EcoRI. (B) Southern blot analysis of 10.5 dpc
embryo. Genomic DNA obtained from yolk sacs was digested with EcoRI and
hybridized with the probe shown in panel A. Fragments obtained from wild type
and targeted alleles are indicated. (C) Embryonic lethality of mARID3b-null
mouse. Frequencies of genotype obtained from intercrosses of mARID3b+/−.
No mARID3b-null embryo was obtained after 15.5 dpc. Though some null
embryos survived until 12.5 dpc, almost all died before 11.5 dpc. Numbers in
parenthesis represent number of embryos showing typical phenotype.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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In 8.5 dpc embryos, it is expressed in the prorhombomere and
the tail bud, where the neural tube remains open (Fig. 2C),
although expression was barely detectable in the trunk area
where the neural tube is already closed. The signal was also
detected in a few nascent somites. In 9.5 dpc embryos, a high
level of expression is detected from the proximal to the distal
regions of the BA2 and BA3 (Fig. 2D). In the BA1, the
expression was more restricted to the distal region, and
expression continues in the tail bud and nascent somites (Fig.
2E). At 10.5 dpc, mARID3b expression was observed to be
down-regulated in the regions of BAs and somites, whereas it
was still maintained in the tail tip (Fig. 2F).
On transverse sections of 8.5 dpc embryos, the expression
was observed in neuroepithelium overlying origin of trigeminal
neural crest (Fig. 2G), a dorsal side of tissue at first branchial
groove (Fig. 2H), which contains a prospective BA2 tissue, and
an epithelium of BA1 (Fig. 2H). The expression was also
detected in a caudal neuroepithelium and mesoderm (Fig. 2I).
At 9.5 dpc, a high level of mARID3b expression was detected
mostly in mesenchymal cells in the facio-acoustic neural crest
complex (Fig. 2J), in the lateral portion of the otic vesicle (Fig.
2K), in the mesenchyme of BA2 (Fig. 2K) and in the caudal
region. Expression was also observed in the ectoderm of BA1
(Fig. 2K), the pharyngeal ectoderm of the 1st branchial pouch
and the wall of the outflow tract (OFT) (Fig. 2L). In the caudal
region, expression was detected in some newly formed somites
and neural tubes (Figs. 2M and N).
Our analyses of mARID3b expression showed that (1)
mARID3b is strongly expressed in cranial mesenchyme and
caudal mesoderm; (2) the expression of cranial mesenchyme is
rapidly down-regulated by 10.5 dpc; (3) in adult tissue, a few
organs, including testes, prostate, thyroid and thymus, express
this gene. Of particular note is that a significant overlap exists
between the mARID3b+ and PDGFRα+ areas in mesodermal
and cranial mesenchymal tissues, except in the somite region. In
8.5 dpc and 9.5 dpc, PDGFRα is widely expressed in almost all
somites (Takakura et al., 1997) (Supplementary Fig. 1), whereas
mARID3b is expressed restrictively in newly formed somites.
mARID3b-null phenotype
To analyze the embryonic function of mARID3b, we
generated mARID3b-null mice according to the knockout
strategy described in Figs. 3A and B. This procedure results in
an allele whose expression can be tracked by LacZ expression.
Sibling matings of heterozygotes produced no live born
homozygous pups (data not shown), indicating lethality in the
mutant embryos. Timed pregnant mothers were dissected on
embryonic days 7.5 dpc to 15.5 dpc to establish the number
and genotypes of the fetus in each litter (Fig. 3C). As the
number of homozygous embryos dropped abruptly at 12.5
dpc, we concentrated our analysis on embryos younger than
12.5 days.
At 9.5 dpc, approximately 60% of null embryos showed
dilated hearts, head deformities and small BAs (left panel in Fig.
4A). The remaining 40% of the null embryos displayed onlysmall body size (center panel in Fig. 4A). The phenotype of 10.5
dpc-null embryo was even more severe than that of 9.5 dpc.
Null embryos displayed two distinct phenotypes; one group
showed only growth retardation (40%, 6/15) (center embryo in
Fig. 4B), while the other group, in addition to growth
retardation, had an arrested heart looping with dilated
pericardial sacs, wavy neural tube (lower left panel in Fig.
4B), hypoplasia of BAs and a small craniofacial structure (60%,
9/15) (left embryo in Fig. 4B). Null mutants rarely survived to
12.5 dpc (4.7%, 2/43). In these surviving mutants, the major
phenotypes have (1) massive bleeding around major vessels,
heart and liver (Supplementary Fig. 5A), (2) wavy neural tube
(Supplementary Fig. 5B) and (3) small BAs (Supplementary
Fig. 5C).
Defect in vascular remodeling
The 10.5 dpc-null mutants were classified into two groups:
embryos with growth retardation without obvious malforma-
tions and those with severe malformations. The null mutant
mice with severe phenotypes exhibited abnormalities in their
cardiovascular system (Figs. 4C–F). At 10.5 dpc, although
hematopoietic cells were detected in blood vessels, any
distinction between large and small blood vessels was barely
observable in the yolk sac of mARID3b-null mice (Supple-
mentary Fig. 5D). To further examine this defect, we examined
the expression of CD31 (PECAM1), an endothelial cell marker.
Though CD31+ endothelial cells differentiate to form a vascular
network in the yolk sacs of the null mutants, vascular
remodeling from the primitive plexus to the higher order
Fig. 4. Phenotype of mARID3b-null embryo. (A and B) Phenotype of mARID3b-null embryos at 9.5 dpc (A) and 10.5 dpc (B). At 9.5 dpc, approximately 60% of total
null embryos display a dilated heart and small BA1 (left embryo in A). The remaining 40% show only growth retardation (middle embryo in A), compared to wild type
embryos (right embryo in A). At 10.5 dpc, approximately 60% of null embryos (left embryo in B) exhibit arrested heart tube looping, dilated pericardial sacs,
hypoplasia of BAs, small craniofacial structures and wavy neural tubes (left lower small panel in B), whereas the remainders show growth retardation (middle embryo
in B), compared with wild type littermates (right embryo in B). Scale bars indicate 500 μm. (C–F) Defect of vascular remodeling in mARID3b-null embryos.
Endothelial cells are visualized by immunostaining of CD31 (PECAM1). The vasculature in the yolk sac of the mutant (C) and the control (D) mice. A distinction
between large and small vessels is found only in the control yolk sac. The vasculature in the embryo of the null mutant (E) and control (F) mouse. In the mutant embryo,
vascular remodeling is severely impaired. Despite the severe defect in remodeling, intersomitic arteries develop from the dorsal aorta of the null mutant (inset picture in
E). Scale bars: 100 μm (C and D); 200 μm (E and F).
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blood vessels is severely impaired, compared to the yolk sac of
the wild type embryo (Figs. 4C and D). Vascular remodeling is
severely impaired in actual mutant embryos (Figs. 4E and F),
though dorsal aorta and intersomitic arteries are formed to a
certain extent (inset in Fig. 4E). This suggests that vascular
endothelial cells are generated in the null mutant and form the
primitive plexus but fail to undergo remodeling. Despite such a
severe phenotype in the vascular system, mARID3b expression
was barely detectable in both vascular endothelial cells and
mural cells of wild type embryos (Fig. 2D). To confirm the
absence of mARID3b expression in endothelial cells, we
purified CD31+CD45− fractions from dissociated 9.5 dpcembryos and analyzed mARID3b expression by RT-PCR. No
mARID3b expression was detected in this population (Supple-
mentary Figs. 5E and F).
In severe phenotype mutants at 10.5 dpc, heart
formation was arrested in the middle of the looping of
the heart tube (Fig. 4B). Despite this, cardiac muscles
were present (Supplementary Figs. 5G and H), and beating
was indeed detected at 9.5 dpc. Moreover, the expression
of mARID3b is barely observed in the developing heart
muscle (Figs. 2D and L, Supplementary Figs. 5I and J).
Taken together, mARID3b may not have a cell-autonomous
role in the differentiation of endothelial cells and cardiac
muscles.
33A. Takebe et al. / Developmental Biology 293 (2006) 25–37Severe impairment in generation of cranial mesenchymal cell
in the mARID3b-null mutant
The most conspicuous defects in 10.5 dpc-null mutants
consisted of hypoplasia of BAs and small craniofacial structures.
Histological analysis of sections revealed a marked reduction in
the number of mesenchymal cells putatively derived from neural
fold. In normal 9.5 dpc embryos, BA1 and BA2 contain dense
populations of mesenchymal cells, while they are almost
completely absent from the same regions in the mutant embryos
(Figs. 5A and B). A similar reduction in cell number is also
found in the facio-acoustic neural crest complex and in the
vicinity of the otic vesicles (Figs. 5A and B). In contrast to the
cranial region, the reduction of mesenchymal cells in the trunk of
null mutants is less conspicuous, though their development is
still impaired to some extent (data not shown).Fig. 5. Severe reduction of cranial mesenchymal cells in mARID3b-null embryo. (A–D
dpc, cellularity of mesenchyme tissue in BA1 and BA2 is severely reduced (arrow
mesenchymal cells (arrowheads in B). At the OFT level, the density of cranial mesenc
detected (C), though the dorsal aorta can be easily recognized at the caudal level (inset
(C, indicated by an arrowhead), and their hemorrhaging into the pericardial cavity is
cardinal vein are easily detected in wild type embryo (D). Abbreviation: (V) ventricula
fluorescent indicating active apoptosis. Transverse section at the level of the BAs in
only in the facial–acoustic neural crest complex but also in the mesenchyme of BA1 a
head neural tube (E). (G and H) 4′-6-Diamidino-2-phenylindole (DAPI) staining of
views of areas marked by squares in panels E and F are shown in panels G and H. In
mutant (G, indicated by arrowheads), suggesting that the cell death with apoptosis in c
mARID3b+ cells. LacZ expression indicated by red arrowheads is detected at the dista
but also in those with severe phenotype (J). The signal is detected in the heterozygouIn section analysis of the heart, clots, probably due to
coagulation, are often found at the OFT of the heart in mutant
embryos, suggesting the presence of a blockade in circulation
(Figs. 5C andD). In keepingwith this hypothesis, the dorsal aorta
and the cardinal vein in the section at OFT level are often difficult
to distinguish (Figs. 5C and D), whereas the dorsal aorta in the
trunk was easily distinguishable from other vessels (lower small
panel in Fig. 5C). As the OFT tissue is known to be derived from
PDGFRα+ cranial mesenchymal cells which have an essential
role in the proper formation of OFT (Tallquist and Soriano,
2003), the defect of OFT formation is consistent with the
significant decrease in the number of cranial mesenchymal cells.
In order to investigate whether or not the loss of mesenchymal
cells is ascribed to enhanced apoptosis, we performed TUNEL
and DAPI staining. Extensive increase of TUNEL-stained cells
was detected in both NCC complex and BA1 and 2 (Figs. 5E and) HE staining of sections at BA level (A and B) and OFT level (C and D). At 9.5
heads in A). In contrast, BA1 and BA2 contain dense populations of cranial–
hymal cells is markedly reduced, and the dorsal aorta and cardinal vein are barely
in C). Cell aggregates, presumably due to coagulation, were detected at the OFT
frequently observed in null embryos (C). The dorsal aorta (arrowhead in D) and
r chamber. (E and F) TUNEL analysis of cranial mesenchyme. TUNEL+ cells are
9.5 dpc mARID3b-null mutant (E) shows an extensive increase of apoptosis not
nd 2, compared to the wild type embryo (F). This increase is also observed in the
serial sections to those shown in panels E and F, respectively. Highly magnified
contrast to wild type embryos (H), many nuclear fragmentations are observed in
ranial mesenchymal cells is enhanced in the null embryo. (I–L) LacZ tracking of
l end of BA1 and BA2, not only in the mutant embryo with a mild phenotype (I)
s embryo (K) but not in the wild type embryo (L). Scale bars indicate 200 μm.
Fig. 6. Similarity between mARID3b-null and PDGFRα-null mutant mice. (A
and B) Phenotype of Ph/Ph mutant mouse. At 9.5 dpc, the phenotype of the Ph/
Ph mutant that bears a large deletion in the region containing whole PDGFRα
coding region is similar to that of mARID3b-null mutants. Ph/Ph embryo shows
poorly formed BAs, failure in cardiogenesis with an enlarged pericardium (A)
and wavy neural tube (B). (C) mARID3b expression in 9.5 dpc Ph/Ph mutant
mouse. By whole-mount ISH of mARID3b, mARID3b expression was detected
in BAs (right lower panel in C) and the caudal region containing neural tube and
somites (left lower panel in C). (D) PDGFRα expression in 9.5 dpc mARID3b-
null mouse. The expression of PDGFRα is detected in BAs (right lower panel in
D) and nascent somites (left lower panel in D). These results suggest that
mARID3b and PDGFRα do not interact directly. Scale bars indicate 200 μm.
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in head neural tube. Consistent with these results, an increase in
the number of dead cells with fragmented nuclei was observed in
regions that are normally filled with mARID3b-expressing
cranial mesenchymal cells (Figs. 5G and H). This increase in
apoptotic and dead cells, however, was not observed in the
caudal region where mARID3b-expressing mesoderm cells exit
(data not shown). Taken together, these results suggest that
apoptosis is the major cellular mechanism underlying this defect
of cranial mesenchymal cells.
In an attempt to further specify the cellular basis for the
failure to generate cranial mesenchymal cells, we investigated
the distribution of LacZ+ cells in null mutant embryos, which
represent an mARID3b+ lineage but are generated in the
absence of mARID3b function. LacZ staining was detected in
the regions where endogenous mARID3b expression is
observed, regardless of phenotypic severity (Figs. 5I–L). This
shows that, although cells expressing mARID3b were generated
and migrated into the distal region of BAs, they could not be
maintained. These results also suggest a role for mARID3b in
cranial mesenchymal cell survival.
Comparison with PDGFRα KO mouse
mARID3b KO embryos share a number of common features
with PDGFRα KO embryos, such as wavy neural tubes, failure
in cardiogenesis with an enlarged pericardium, facial deformity
and poorly formed BAs, especially so when the mutant allele is
introduced into a C57BL/6 background (Soriano, 1997) (Figs.
6A and B). Although mARID3b is expressed more transiently
and in more restricted areas than PDGFRα, symptoms are
actually more severe in mARID3b- than PDGFRα-null
embryos. Despite this, mARID3b expression is detected in
Ph/Ph mouse that have large deletions, including the gene
encoding PDGFRα (Fig. 6C) (Stephenson et al., 1991).
Likewise, PDGFRα+ mesenchymal cells are present in
mARID3b-null mouse (Fig. 6D). It is therefore likely that the
two molecules are required for independent processes during
differentiation of paraxial mesoderm and mesenchyme derived
from neural fold.
Discussion
Combinatory use of ES cell cultures and microarray analysis
for identifying genes involved in early embryogenesis
Microarray technology is well suited to comprehensive
analyses of changes in transcriptional activity that underlie cell
specification during embryogenesis (Debouck and Goodfellow,
1999; Smith and Greenfield, 2003). However, use of this
technology for analyzing early mouse embryogenesis has so far
remained limited due to difficulties in collecting a sufficient
number of specific cell populations from developing embryos.
Our group, as well as others, has shown that various
intermediates appearing in the course of embryogenesis can
be induced and purified from ES cell differentiation cultures
(Kabrun et al., 1997; Nishikawa et al., 1998). While the cellvariety obtained by the currently available technology is
limited, this situation will improve along with development of
new technologies for cell culture and purification. As a result,
ES cell culture will become of increasing importance as a non-
substitutable cell source for DNA microarray analysis of
embryonic processes.
However, we are also aware of problems inherent in this
experimental system. Any given populations, even though
purified by using multiple differentiation markers, are likely to
contain heterogeneous populations as available markers are
always limited, and the phenotypes of cells are continuously
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markers. Microarray data of any given population may not
represent a particular status but rather a general tendency of a
differentiation course. We therefore believe that an important
feature in using cells harvested from ES cell differentiation
culture is to collect enough data in such a way as to reflect this
general tendency. Keeping this concept in mind, we performed
microarray analysis of cell populations whenever a particular
cell population was obtained and stored all data in such a way
that a number of different questions could be addressed.
In this study, PDGFRα was chosen as a key marker for
mesodermal and mesenchymal differentiation, and several
intermediates in the mesoderm differentiation pathways were
analyzed. Using our own software, we listed 30 genes with
expression patterns similar to PDGFRα. As we could list many
genes that have been implicated in development of either
mesoderm, cranial mesenchyme or NCC, our approach appears
useful for identifying genes involved in embryonic develop-
ment. However, it should be noted that 8 distinct samples
analyzed in this study contain neither NCC nor cranial
mesenchymal cells. Thus, our method for gene discovery,
which compared multiple samples derived from ES cell
differentiation cultures, does not necessarily list genes that are
expressed specifically in the development of intermediates
selected for analysis. Nonetheless, as PDGFRα is expressed
also in cranial mesenchyme and NCC, our method may have an
ability to rank genes commonly involved in multiple differen-
tiation pathways for PDGFRα+ cells, though underlying
rationale of our application is yet to be determined by applying
it to different settings.
Role of mARID3b in embryogenesis
In addition to molecules that have already been character-
ized to a significant extent, our list of 30 genes with
expression patterns similar to PDGFRα includes several
molecules whose role in embryogenesis has been yet to be
explored. One such molecule, mARID3b, expressed mainly in
paraxial mesoderm and cranial mesenchyme, was further
analyzed in this study. We generated mARID3b-null mutant
mice in which lacZ expression is used for tracking
endogenous mARID3b expression.
The null mutants showed an embryonic lethality before
11.5 dpc. While the phenotypes of mutant embryos do vary
among embryos, the three most common defects were: (1)
wavy neural tube, (2) small branchial arches and (3) defect of
cardiovascular system. It is interesting that these defects have
also been found in PDGFRα-null mutant embryos as we
listed mARID3b as a gene whose expression pattern is similar
to PDGFRα (Soriano, 1997). In fact, mARID3b expression
overlaps with that of PDGFRα in both cranial mesenchymal
and caudal mesodermal regions including nascent somites
(Takakura et al., 1997). It is therefore plausible to suggest that
PDGFRα and mARID3b are directly interacting with each
other during the development of PDGFRα+ cells. However,
as expression of mARID3b and PDGFRα is maintained by
null mutation of PDGFRα and mARID3b genes, respectively,it is more likely that the two molecules are involved in
independent processes. Consistent with this view is a previous
report on cranial mesenchyme specific conditional knockout
of PDGFRα, showing that PDGFRα is involved in
differentiation of cranial mesenchymal cells rather than their
survival (Tallquist and Soriano, 2003). In contrast to this,
mARID3b's role in cranial mesenchymal cells is to prevent
their apoptosis.
One of the most conspicuous phenotypes of mARID3b-null
mutants is a defect in the development of the cardiovascular
system. However, mARID3b expression was undetectable both
in cardiac muscle and blood vessels during all stages of
embryogenesis. Moreover, endothelial cells, as well as cardiac
muscles, can differentiate in the mutant embryos. It is likely that
mARID3b does not play a cell-autonomous role in differenti-
ation of endothelial and cardiac muscle cells. Concerning the
cardiovascular phenotype, we found that mARID3b-null
embryos show a marked resemblance to dHand-null mutant
embryos (Srivastava et al., 1997; Thomas et al., 1998). While
dHand was shown to have a direct role in the formation of
ventricular muscles, the defect of heart formation in dHand-null
mutant is mainly due to branchial arch growth failure from
apoptosis. The fact that growth of branchial arch cells is
severely impaired by apoptosis in mARID3b-null mutant
embryos leads us to speculate that the cellular process causing
cardiac defect of the mARID3b-null mutant mouse is due to a
failure in recruiting cranial mesenchymal cells. As heart
function is required for vascular remodeling, circulation defects
may account for the majority of defects in vascular remodeling.
The reduction in cranial mesenchyme production may also
account for the occlusion of the dorsal aorta and cardinal vein as
mesoderm and cranial mesenchyme are known to migrate to
remote sites and are involved in formation of various tissues.
Although the phenotype of KO embryos appears to be
complicated in initial observations, we speculate that the
cellular processes responsible for the major phenotypes of
mARID3b-null mutant mice can be simply ascribed to the
failure in recruiting cranial mesenchymal cells to the area where
they migrate.
This study shows that enhanced apoptosis is the major
cellular basis for the defect of growth of cranial mesenchymal
cells in mARID3b-null mutants. hARID3A, the closest member
to hARID3B, acts as a positive regulator of cell proliferation.
Over expression of this molecule can immortalize mouse
embryonic fibroblasts (MEF) through bypassing the H-
RASV12-induced senescence (Peeper et al., 2002). As the
DNA binding domain of hARID3A, which is essential for ARID
family function (Wilsker et al., 2002), is very similar to that of
mARID3b, it is plausible that mARID3b acts in a similar manner
to hARID3A in cranial mesenchymal cells. Our observation that
their growth is impaired from massive cell death is consistent
with this possibility. During embryogenesis, there are numerous
situations in which a large number of a particular cell type need
to be prepared in a short period of time. While induction of cell
proliferation is usually mediated by external signals, strong
growth signals are often associated with cell senescence. We
speculate that transient expression of senescence bypassing
36 A. Takebe et al. / Developmental Biology 293 (2006) 25–37mechanisms, such as mARID3b, according to a developmental
program is a common mechanism for expanding a particular
population.
This study shows that the mARID3b molecule is indispens-
able for the production of cranial mesenchymal tissues. As
studies of ARID family molecules in mammalian embryogen-
esis are still limited, our present report has the potential to shed
new light on novel molecular mechanisms regulating the
production of proper amounts of cells.Acknowledgments
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